Tharimmune, Inc. (NASDAQ:THAR – Get Free Report) shares were down 3.2% on Wednesday . The company traded as low as $0.37 and last traded at $0.38. Approximately 216,216 shares traded hands during mid-day trading, a decline of 66% from the average daily volume of 635,400 shares. The stock had previously closed at $0.39. Tharimmune Trading […]
Tharimmune (NASDAQ:THAR – Get Free Report) is one of 913 public companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We will compare Tharimmune to similar companies based on the strength of its analyst recommendations, risk, profitability, institutional ownership, dividends, valuation and earnings. Profitability This table compares Tharimmune […]
Shares of Tharimmune, Inc. (THAR) are up 33% on Monday after the company announced positive phase 1 data for its proprietary transmucosal buccal film product, TH104, that adheres easily to the inside of the mouth, making it a convenient solution for patients.